These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 25063430)
1. NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease. Zhang H; Petit GH; Gaughwin PM; Hansen C; Ranganathan S; Zuo X; Smith R; Roybon L; Brundin P; Mobley WC; Li JY J Huntingtons Dis; 2013; 2(1):69-82. PubMed ID: 25063430 [TBL] [Abstract][Full Text] [Related]
2. Behavioural state differentially engages septohippocampal cholinergic and GABAergic neurons in R6/1 Huntington's disease mice. Ransome MI; Hannan AJ Neurobiol Learn Mem; 2012 Feb; 97(2):261-70. PubMed ID: 22261461 [TBL] [Abstract][Full Text] [Related]
3. Cholinergic neuronal defect without cell loss in Huntington's disease. Smith R; Chung H; Rundquist S; Maat-Schieman ML; Colgan L; Englund E; Liu YJ; Roos RA; Faull RL; Brundin P; Li JY Hum Mol Genet; 2006 Nov; 15(21):3119-31. PubMed ID: 16987871 [TBL] [Abstract][Full Text] [Related]
4. Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1. Fedele V; Roybon L; Nordström U; Li JY; Brundin P Neuroscience; 2011 Jan; 173():76-81. PubMed ID: 20807561 [TBL] [Abstract][Full Text] [Related]
5. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice. Ransome MI; Hannan AJ Mol Cell Neurosci; 2013 May; 54():93-107. PubMed ID: 23384443 [TBL] [Abstract][Full Text] [Related]
6. Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease. Kohl Z; Kandasamy M; Winner B; Aigner R; Gross C; Couillard-Despres S; Bogdahn U; Aigner L; Winkler J Brain Res; 2007 Jun; 1155():24-33. PubMed ID: 17512917 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models. Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655 [TBL] [Abstract][Full Text] [Related]
9. Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits. Chen KS; Nishimura MC; Armanini MP; Crowley C; Spencer SD; Phillips HS J Neurosci; 1997 Oct; 17(19):7288-96. PubMed ID: 9295375 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington's disease. Choi ML; Begeti F; Oh JH; Lee SY; O'Keeffe GC; Clelland CD; Tyers P; Cho ZH; Kim YB; Barker RA Neurobiol Dis; 2014 Jun; 66():19-27. PubMed ID: 24561069 [TBL] [Abstract][Full Text] [Related]
11. Neurotrophic factors rescue basal forebrain cholinergic neurons and improve performance on a spatial learning test. Lee YS; Danandeh A; Baratta J; Lin CY; Yu J; Robertson RT Exp Neurol; 2013 Nov; 249():178-86. PubMed ID: 24017996 [TBL] [Abstract][Full Text] [Related]
12. PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model. Giralt A; Saavedra A; Carretón O; Arumí H; Tyebji S; Alberch J; Pérez-Navarro E Hippocampus; 2013 Aug; 23(8):684-95. PubMed ID: 23576401 [TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor improves spatial learning and restores hippocampal cholinergic fibers in rats withdrawn from chronic treatment with ethanol. Lukoyanov NV; Pereira PA; Paula-Barbosa MM; Cadete-Leite A Exp Brain Res; 2003 Jan; 148(1):88-94. PubMed ID: 12478399 [TBL] [Abstract][Full Text] [Related]
14. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice. Seo H; Isacson O Exp Neurol; 2005 Jun; 193(2):469-80. PubMed ID: 15869949 [TBL] [Abstract][Full Text] [Related]
15. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation. Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761 [TBL] [Abstract][Full Text] [Related]
16. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats. Hernandez CM; Gearhart DA; Parikh V; Hohnadel EJ; Davis LW; Middlemore ML; Warsi SP; Waller JL; Terry AV J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877 [TBL] [Abstract][Full Text] [Related]
17. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease. Giralt A; Saavedra A; Carretón O; Xifró X; Alberch J; Pérez-Navarro E Hum Mol Genet; 2011 Nov; 20(21):4232-47. PubMed ID: 21835884 [TBL] [Abstract][Full Text] [Related]
18. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Gil JM; Mohapel P; Araújo IM; Popovic N; Li JY; Brundin P; Petersén A Neurobiol Dis; 2005 Dec; 20(3):744-51. PubMed ID: 15951191 [TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor promotes survival of new neurons in the adult hippocampus. Frielingsdorf H; Simpson DR; Thal LJ; Pizzo DP Neurobiol Dis; 2007 Apr; 26(1):47-55. PubMed ID: 17270453 [TBL] [Abstract][Full Text] [Related]
20. Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease. Ciamei A; Morton AJ Neurobiol Learn Mem; 2009 Oct; 92(3):417-28. PubMed ID: 19524696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]